Šárka Štěpánková

696 total citations
47 papers, 582 citations indexed

About

Šárka Štěpánková is a scholar working on Pharmacology, Computational Theory and Mathematics and Organic Chemistry. According to data from OpenAlex, Šárka Štěpánková has authored 47 papers receiving a total of 582 indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Pharmacology, 31 papers in Computational Theory and Mathematics and 27 papers in Organic Chemistry. Recurrent topics in Šárka Štěpánková's work include Cholinesterase and Neurodegenerative Diseases (40 papers), Computational Drug Discovery Methods (31 papers) and Synthesis and biological activity (11 papers). Šárka Štěpánková is often cited by papers focused on Cholinesterase and Neurodegenerative Diseases (40 papers), Computational Drug Discovery Methods (31 papers) and Synthesis and biological activity (11 papers). Šárka Štěpánková collaborates with scholars based in Czechia, South Korea and Spain. Šárka Štěpánková's co-authors include Martin Krátký, Jarmila Vinšová, Karel Komers, Alexander Čegan, Lubomı́r Opletal, Vladimír Pejchal, Lucie Cahlíková, Alena Komersová, Jakub Chlebek and Anna Hošťálková and has published in prestigious journals such as Bioresource Technology, International Journal of Molecular Sciences and Molecules.

In The Last Decade

Šárka Štěpánková

45 papers receiving 574 citations

Peers

Šárka Štěpánková
Šárka Štěpánková
Citations per year, relative to Šárka Štěpánková Šárka Štěpánková (= 1×) peers Mustafa Küçükislamoğlu

Countries citing papers authored by Šárka Štěpánková

Since Specialization
Citations

This map shows the geographic impact of Šárka Štěpánková's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Šárka Štěpánková with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Šárka Štěpánková more than expected).

Fields of papers citing papers by Šárka Štěpánková

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Šárka Štěpánková. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Šárka Štěpánková. The network helps show where Šárka Štěpánková may publish in the future.

Co-authorship network of co-authors of Šárka Štěpánková

This figure shows the co-authorship network connecting the top 25 collaborators of Šárka Štěpánková. A scholar is included among the top collaborators of Šárka Štěpánková based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Šárka Štěpánková. Šárka Štěpánková is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Komersová, Alena, et al.. (2024). New biologically active sulfonamides as potential drugs for Alzheimer's disease. Archiv der Pharmazie. 357(10). e2400191–e2400191. 3 indexed citations
2.
González, Gabriel, et al.. (2024). Novel neuroprotective 5,6-dihydropyrido[2′,1':2,3]imidazo[4,5-c]quinoline derivatives acting through cholinesterase inhibition and CB2 signaling modulation. European Journal of Medicinal Chemistry. 276. 116592–116592. 10 indexed citations
3.
González, Gabriel, Šárka Štěpánková, Marek Zatloukal, et al.. (2023). Synthesis and neuroprotective activity of 3‐aryl‐3‐azetidinyl acetic acid methyl ester derivatives. Archiv der Pharmazie. 356(12). e2300378–e2300378.
4.
Krátký, Martin, et al.. (2023). New 3-Amino-2-Thioxothiazolidin-4-One-Based Inhibitors of Acetyl- and Butyryl-Cholinesterase: Synthesis and Activity. Future Medicinal Chemistry. 16(1). 59–74. 2 indexed citations
5.
Štěpánková, Šárka, et al.. (2023). Novel Inhibitors of Acetyl- and Butyrylcholinesterase Derived from Benzohydrazides: Synthesis, Evaluation and Docking Study. Pharmaceuticals. 16(2). 172–172. 3 indexed citations
6.
González, Gabriel, Miroslav Kvasnica, Šárka Štěpánková, et al.. (2022). Ring-fused 3β-acetoxyandrost-5-enes as novel neuroprotective agents with cholinesterase inhibitory properties. The Journal of Steroid Biochemistry and Molecular Biology. 225. 106194–106194. 5 indexed citations
8.
Krátký, Martin, Šárka Štěpánková, Annalisa Maruca, et al.. (2021). Novel propargylamine-based inhibitors of cholinesterases and monoamine oxidases: Synthesis, biological evaluation and docking study. Bioorganic Chemistry. 116. 105301–105301. 13 indexed citations
9.
Krátký, Martin, Šárka Štěpánková, Klára Konečná, et al.. (2021). Novel Aminoguanidine Hydrazone Analogues: From Potential Antimicrobial Agents to Potent Cholinesterase Inhibitors. Pharmaceuticals. 14(12). 1229–1229. 14 indexed citations
10.
Jorda, Radek, Gabriel González, Jacek W. Morzycki, et al.. (2020). The synthesis and cholinesterase inhibitory activities of solasodine analogues with seven-membered F ring. The Journal of Steroid Biochemistry and Molecular Biology. 205. 105776–105776. 9 indexed citations
11.
Krátký, Martin, Zsuzsa Baranyai, Šárka Štěpánková, et al.. (2020). N-Alkyl-2-[4-(trifluoromethyl)benzoyl]hydrazine-1-carboxamides and Their Analogues: Synthesis and Multitarget Biological Activity. Molecules. 25(10). 2268–2268. 14 indexed citations
12.
Chlebek, Jakub, Jan Korábečný, Rafael Doležal, et al.. (2019). In Vitro and In Silico Acetylcholinesterase Inhibitory Activity of Thalictricavine and Canadine and Their Predicted Penetration across the Blood-Brain Barrier. Molecules. 24(7). 1340–1340. 27 indexed citations
14.
Krátký, Martin, et al.. (2017). Synthesis of readily available fluorophenylalanine derivatives and investigation of their biological activity. Bioorganic Chemistry. 71. 244–256. 9 indexed citations
15.
Krátký, Martin, et al.. (2016). Synthesis and in vitro evaluation of novel rhodanine derivatives as potential cholinesterase inhibitors. Bioorganic Chemistry. 68. 23–29. 26 indexed citations
16.
Hošťálková, Anna, Marcela Šafratová, Jiřı́ Kuneš, et al.. (2016). Isolation of Amaryllidaceae alkaloids from Nerine bowdenii W. Watson and their biological activities. RSC Advances. 6(83). 80114–80120. 27 indexed citations
17.
Pejchal, Vladimír, Šárka Štěpánková, Marcela Pejchalová, et al.. (2016). Synthesis, structural characterization, docking, lipophilicity and cytotoxicity of 1-[(1R)-1-(6-fluoro-1,3-benzothiazol-2-yl)ethyl]-3-alkyl carbamates, novel acetylcholinesterase and butyrylcholinesterase pseudo-irreversible inhibitors. Bioorganic & Medicinal Chemistry. 24(7). 1560–1572. 24 indexed citations
18.
Imramovský, Aleš, Vladimír Pejchal, Šárka Štěpánková, et al.. (2013). Synthesis and in vitro evaluation of new derivatives of 2-substituted-6-fluorobenzo[d]thiazoles as cholinesterase inhibitors. Bioorganic & Medicinal Chemistry. 21(7). 1735–1748. 37 indexed citations
19.
Kovářová, Markéta, Karel Komers, Šárka Štěpánková, & Alexander Čegan. (2010). Inhibition of acetylcholinesterase by 14 achiral and five chiral imidazole derivates. Bioresource Technology. 101(15). 6281–6283. 4 indexed citations
20.
Štěpánková, Šárka, et al.. (2005). Two New Methods Monitoring Kinetics of Hydrolysis of Acetylcholine and Acetylthiocholine. Zeitschrift für Naturforschung C. 60(11-12). 943–946. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026